A case links cannabis withdrawal relief to rapid symptom resolution
Gabapentin for the Management of Suspected Cannabis Withdrawal in a Pregnant Patient With a History of Cannabinoid Hyperemesis Syndrome: A Case Report.
AI Summary
Cannabinoid hyperemesis syndrome (CHS) can resemble severe pregnancy-related vomiting, making diagnosis difficult. This case involved a 24-year-old pregnant patient at 20 weeks’ gestation who had recurrent nausea, vomiting, labile hypertension, a previous CHS hospitalization, and cannabis use disorder. Her recent reduction in cannabis use raised concern that cannabis withdrawal was contributing to her symptoms.
After consultation with Addiction Medicine, clinicians used gabapentin off-label. Symptoms resolved and blood pressure normalized within 24 hours, with no apparent maternal or fetal complications reported. However, this is a single case report—not evidence that gabapentin is broadly effective or proven safe during pregnancy. The report’s main practical message is that healthcare professionals should ask about cannabis use, recent reduction or cessation, and withdrawal when evaluating severe or persistent vomiting in pregnancy.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More Addiction research papers you might find interesting.
U.S. survey finds distinct patterns of frequent alcohol, nicotine, and…
Treatment records show a sharp rise in stimulant use in Oman, 2019–2024
An 18-month cohort found adverse outcomes were infrequent, but long-term risks…
Explore More Research
Stay informed about the latest cannabis science.